Darodipine (PY108-068, PY-108068) is a potent calcium channel antagonist; it increases the number and average length of alkaline phosphatase-reactive capillaries and reduces intercapillary distance and cerebral capillary diameter in aged rats; it may ameliorate neuronal cytoskeletal alterations associated with aging and neurodegenerative disorders; chronic oral administration (10 mg/kg/day for 6 months, from the 18th to the 24th month of life) partially restores the expression of 200 kDa neurofilament subunit immunoreactivity in the cerebellar cortex.